Read more
The increase in the incidence of fungal infections, given the small therapeutic arsenal available for their treatment, has generated a growing interest in fungi and the mycoses they cause. Paracoccidioidomycosis (PCM) is part of this context, as it is a systemic mycosis that is endemic to Latin America and most often manifests itself in immunocompetent hosts and has different clinical forms. It is not compulsorily notifiable, making it difficult to ascertain its prevalence and incidence. Therefore, this work refers to a narrative literature review, consisting of national and international publications in the field of mycology with the aim of gathering a set of information on the profile of PCM, its etiological agents, epidemiology, clinical aspects, diagnosis and therapy of the disease.
About the author
Licenciada en Farmacia por la Universidad Estatal de Paraíba (1983), diplomada en Análisis Clínicos por la Universidad Federal de Paraíba (1986), máster en Métabolisme des Médicaments et Pharmacologie Clinique Universite de Nancy I - Francia (1991) y doctora en Productos Bioactivos Naturales y Sintéticos por la Universidad Federal de Paraíba (2002).